PP_1170x120_10-25-21

Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”

Pharmacy united in call for President Trump to act on DIR fee reform

Pharmacy united in call for President Trump to act on DIR fee reform

WASHINGTON — Action by the Trump Administration, Congress or both is needed now to provide relief from pharmacy direct and indirect remuneration (DIR) fees that inflate drug costs paid by patients and the government, and that force pharmacies to fill Medicare prescriptions often below cost. That was the message delivered Monday in a letter to

NACDS, NCPA praise senate action to reduce patient drug costs

NACDS, NCPA praise senate action to reduce patient drug costs

WASHINGTON — The National Association of Chain Drug Stores (NACDS) and the National Community Pharmacists Association (NCPA) Tuesday praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar. The letter thanked the Secretary for concepts in the Centers for Medicare & Medicaid Services’ (CMS) proposed rule, Modernizing Part D and Medicare Advantage

NACDS demonstrates need for DIR fee reform in comments to CMS

NACDS demonstrates need for DIR fee reform in comments to CMS

ARLINGTON, Va.—Based on insights from member pharmacies that serve as the front lines of healthcare delivery, the National Association of Chain Drug Stores (NACDS) has submitted extensive and thoroughly documented comments to the Centers for Medicare & Medicaid Services in support of the agency’s proposal to reform direct and indirect remuneration (DIR) fees – reform

Pharmacy groups praise CMS’ progress on DIR reform

Pharmacy groups praise CMS’ progress on DIR reform

WASHINGTON – The National Community Pharmacists Association, the National Association of Chain Drug Stores, and the National Association of Specialty Pharmacy issued the following statement regarding the Centers for Medicare & Medicaid Services’ (CMS) release on Monday of the proposed rule titled “Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses”: “The